Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.

Caronna E, Gallardo VJ, Egeo G, Vázquez MM, Castellanos CN, Membrilla JA, Vaghi G, Rodríguez-Montolio J, Fabregat Fabra N, Sánchez-Caballero F, Jaimes Sánchez A, Muñoz-Vendrell A, Oliveira R, Gárate G, González-Osorio Y, Guisado-Alonso D, Ornello R, Thunstedt C, Fernández-Lázaro I, Torres-Ferrús M, Alpuente A, Torelli P, Aurilia C, Pére RL, Castrillo MJR, Icco R, Sances G, Broadhurst S, Ong HC, García AG, Campoy S, Sanahuja J, Cabral G, Beltrán Blasco I, Waliszewska-Prosół M, Pereira L, Layos-Romero A, Luzeiro I, Dorado L, Álvarez Escudero MR, May A, López-Bravo A, Martins IP, Sundal C, Irimia P, Lozano Ros A, Gago-Veiga AB, Juanes FV, Ruscheweyh R, Sacco S, Cuadrado-Godia E, García-Azorín D, Pascual J, Gil-Gouveia R, Huerta-Villanueva M, Rodriguez-Vico J, Viguera Romero J, Obach V, Santos-Lasaosa S, Ghadiri-Sani M, Tassorelli C, Díaz-de-Terán J, Díaz Insa S, Oria CG, Barbanti P, Pozo-Rosich P, EUREkA study group

Open source

DOI: 10.1136/jnnp-2023-333295
Published: 2024 Sep 17
Container: Journal of neurology, neurosurgery, and psychiatry
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jnnp-2023-333295,
  title = {Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.},
  author = {Caronna E and Gallardo VJ and Egeo G and Vázquez MM and Castellanos CN and Membrilla JA and Vaghi G and Rodríguez-Montolio J and Fabregat Fabra N and Sánchez-Caballero F and Jaimes Sánchez A and Muñoz-Vendrell A and Oliveira R and Gárate G and González-Osorio Y and Guisado-Alonso D and Ornello R and Thunstedt C and Fernández-Lázaro I and Torres-Ferrús M and Alpuente A and Torelli P and Aurilia C and Pére RL and Castrillo MJR and Icco R and Sances G and Broadhurst S and Ong HC and García AG and Campoy S and Sanahuja J and Cabral G and Beltrán Blasco I and Waliszewska-Prosół M and Pereira L and Layos-Romero A and Luzeiro I and Dorado L and Álvarez Escudero MR and May A and López-Bravo A and Martins IP and Sundal C and Irimia P and Lozano Ros A and Gago-Veiga AB and Juanes FV and Ruscheweyh R and Sacco S and Cuadrado-Godia E and García-Azorín D and Pascual J and Gil-Gouveia R and Huerta-Villanueva M and Rodriguez-Vico J and Viguera Romero J and Obach V and Santos-Lasaosa S and Ghadiri-Sani M and Tassorelli C and Díaz-de-Terán J and Díaz Insa S and Oria CG and Barbanti P and Pozo-Rosich P and EUREkA study group},
  year = {2024},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  doi = {10.1136/jnnp-2023-333295},
  url = {https://doi.org/10.1136/jnnp-2023-333295}
}

RIS

TY  - JOUR
TI  - Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
AU  - Caronna E
AU  - Gallardo VJ
AU  - Egeo G
AU  - Vázquez MM
AU  - Castellanos CN
AU  - Membrilla JA
AU  - Vaghi G
AU  - Rodríguez-Montolio J
AU  - Fabregat Fabra N
AU  - Sánchez-Caballero F
AU  - Jaimes Sánchez A
AU  - Muñoz-Vendrell A
AU  - Oliveira R
AU  - Gárate G
AU  - González-Osorio Y
AU  - Guisado-Alonso D
AU  - Ornello R
AU  - Thunstedt C
AU  - Fernández-Lázaro I
AU  - Torres-Ferrús M
AU  - Alpuente A
AU  - Torelli P
AU  - Aurilia C
AU  - Pére RL
AU  - Castrillo MJR
AU  - Icco R
AU  - Sances G
AU  - Broadhurst S
AU  - Ong HC
AU  - García AG
AU  - Campoy S
AU  - Sanahuja J
AU  - Cabral G
AU  - Beltrán Blasco I
AU  - Waliszewska-Prosół M
AU  - Pereira L
AU  - Layos-Romero A
AU  - Luzeiro I
AU  - Dorado L
AU  - Álvarez Escudero MR
AU  - May A
AU  - López-Bravo A
AU  - Martins IP
AU  - Sundal C
AU  - Irimia P
AU  - Lozano Ros A
AU  - Gago-Veiga AB
AU  - Juanes FV
AU  - Ruscheweyh R
AU  - Sacco S
AU  - Cuadrado-Godia E
AU  - García-Azorín D
AU  - Pascual J
AU  - Gil-Gouveia R
AU  - Huerta-Villanueva M
AU  - Rodriguez-Vico J
AU  - Viguera Romero J
AU  - Obach V
AU  - Santos-Lasaosa S
AU  - Ghadiri-Sani M
AU  - Tassorelli C
AU  - Díaz-de-Terán J
AU  - Díaz Insa S
AU  - Oria CG
AU  - Barbanti P
AU  - Pozo-Rosich P
AU  - EUREkA study group
PY  - 2024
JO  - Journal of neurology, neurosurgery, and psychiatry
DO  - 10.1136/jnnp-2023-333295
UR  - https://doi.org/10.1136/jnnp-2023-333295
ER  -

APA

E, C., VJ, G., G, E., MM, V., CN, C., JA, M., G, V., J, R., N, F. F., F, S., A, J. S., A, M., R, O., G, G., Y, G., D, G., R, O., C, T., I, F., M, T., A, A., P, T., C, A., RL, P., MJR, C., R, I., G, S., S, B., HC, O., AG, G., S, C., J, S., G, C., I, B. B., M, W., L, P., A, L., I, L., L, D., MR, Á. E., A, M., A, L., IP, M., C, S., P, I., A, L. R., AB, G., FV, J., R, R., S, S., E, C., D, G., J, P., R, G., M, H., J, R., J, V. R., V, O., S, S., M, G., C, T., J, D., S, D. I., CG, O., P, B., P, P., & group, E. S. (2024). Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2023-333295

Source records

pubmed · retrieved 2026-09-27T12:21:10.013Z